Validation of a Urine-based Assay With Genomic Markers for Predicting Recurrence for Non-muscle Invasive Bladder Cancer

Inclusion Criteria:

Patients with a prior diagnosis of non-muscle invasive, ≤T1, urothelial cell carcinoma of the bladder scheduled to undergo surveillance cystoscopy.

Exclusion Criteria:

Patients younger than 18 years
Patients with a diagnosis of small cell carcinoma, adenocarcinoma or squamous cell carcinoma of the bladder
Patients who have had a cystectomy or prior diagnosis of muscle invasive disease (T2 or greater)
Patients who are unable or unwilling to give informed consent